Tirzepatide Diarrhea: Warning Signs and What to Tell Your Clinician

Diarrhea is reported in the prescribing information for Zepbound and Mounjaro, both of which contain tirzepatide. The symptom alone cannot tell you its cause or whether it is safe to wait. Persistent symptoms, fluid loss, pain, fever, or changes in stool appearance need attention. Zepbound prescribing information, section 6.1, Mounjaro prescribing information, section 6.1.

When to get help

Stop using the medicine and get medical help right away for signs of a serious allergic reaction. Both Medication Guides list swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe rash or itching; fainting or feeling dizzy; and a very rapid heartbeat. Zepbound Medication Guide, Mounjaro Medication Guide.

Anaphylaxis is a medical emergency. Call 911 or the local emergency number immediately for severe symptoms. MedlinePlus: anaphylaxis.

Get medical help immediately for confusion, fainting, no urination, rapid heartbeat, or rapid breathing. These can accompany severe dehydration. Diarrhea can cause fluid loss; do not wait for a routine portal reply when these signs are present. MedlinePlus: dehydration.

Severe abdominal pain that does not go away, sometimes extending to the back, needs immediate assessment. Both Medication Guides instruct users to stop the medicine and call their healthcare provider right away for this pain, with or without nausea or vomiting. Upper abdominal pain, fever, yellow skin or eyes, or clay-colored stools also require prompt contact with a healthcare provider because they can signal a gallbladder problem. These warnings are reasons to seek assessment, not diagnoses. Zepbound Medication Guide, Mounjaro Medication Guide.

Both Medication Guides also say to contact your healthcare provider right away for nausea, vomiting, or diarrhea that does not go away. Zepbound Medication Guide, Mounjaro Medication Guide.

For adults, NIDDK advises contacting a doctor right away for diarrhea lasting more than two days, six or more loose stools in a day, high fever, repeated vomiting, blood or black tarry stools, severe pain, or dehydration symptoms. A duration threshold is not permission to wait when warning signs are already present. NIDDK: symptoms and causes of diarrhea.

What do the prescribing labels report?

Both products' August 2026 prescribing information, checked October 8, 2026, list diarrhea among reported adverse reactions. In the placebo-controlled trial pools below, diarrhea was reported more often in treated groups than with placebo.

Sources: Zepbound August 2026 prescribing information, section 6.1, Table 1; Mounjaro August 2026 prescribing information, section 6.1, Table 1.

These are separate trial pools. Their findings cannot establish that one brand is better tolerated than the other, predict your experience, or describe a particular compounded preparation. Reported side effects are not measures of treatment success.

Why might diarrhea happen during treatment?

Medication effects are one possible explanation. Diarrhea can also have other causes, including infections and food poisoning. Starting after a prescription change is useful information for your clinician, but timing alone does not settle the cause. NIDDK: symptoms and causes.

Both labels report that most nausea, vomiting, and diarrhea events occurred during treatment escalation and became less frequent over time. That group pattern does not establish how long your episode will last. Zepbound prescribing information, section 6.1, Mounjaro prescribing information, section 6.1.

Diarrhea is not a signal you can use to judge whether the medicine is working. The checked labels do not identify it as a marker of benefit. Avoid treating a symptom as evidence that a treatment change is needed; ask your prescriber to assess it.

Fluid loss and the kidney warning

Diarrhea and vomiting can lead to dehydration. Both prescribing labels warn about acute kidney injury associated with fluid loss. Zepbound prescribing information, section 5.3, Mounjaro prescribing information, section 5.5.

Dehydration symptoms can include thirst, dry mouth, dark urine, reduced urination, and dizziness. Symptoms do not establish severity on their own. Confusion, fainting, no urination, rapid heartbeat, and rapid breathing require immediate help, as described above. MedlinePlus: dehydration.

Replacing lost fluids matters. NIDDK advises people with diabetes, kidney disease, or other health conditions to ask a doctor about appropriate fluids or oral rehydration solutions. This article does not set a universal water or electrolyte target. NIDDK: treatment of diarrhea.

What about antidiarrheal medicines or my next treatment?

Ask your prescriber or pharmacist before choosing an over-the-counter remedy. NIDDK notes that doctors may advise against these medicines when diarrhea involves fever or bloody stools. A symptom list is not enough to choose a remedy or rule out infection. NIDDK: treatment of diarrhea.

For questions about an upcoming prescribed administration, contact your care team and describe the symptoms. This guide does not provide a routine pause, restart, or dose-change plan. The specific urgent stop-use instructions in the Medication Guides still apply to the severe pain and serious allergy warnings above.

A short symptom record for your clinician

If urgent signs are present, seek care instead of completing a checklist. Otherwise, note:

• When symptoms began and whether they are improving or worsening.
• The number of loose stools and any unusual color, blood, or black tarry appearance.
• Pain, fever, vomiting, difficulty drinking, and changes in urination.
• The exact medicine and formulation, last administration, and recent prescription changes.
• Other medicines or supplements, recent antibiotics, and travel.

These details help organize a clinical history. NIDDK: diagnosis of diarrhea. Treatment chronology is an additional useful detail to share with your prescriber.

You can use this message through your care team's designated channel:

“I am taking [medicine and formulation]. Diarrhea began [when], and I have had [number] loose stools today. I also noticed [pain, fever, vomiting, stool changes, or other symptoms]. I can [describe ability to drink], and my urination has [changed/not changed]. My last administration and recent prescription changes were [details]. Do I need an assessment, and what should I do about my treatment plan?”

Leave unknown details blank. Do not delay necessary care to gather measurements or wait for a message response.

Which products does this information describe?

This article uses evidence for FDA-approved Zepbound and Mounjaro injections. Their trial findings do not establish side-effect frequency, safety, or dosing for a specific compounded tirzepatide preparation. Compounded medicines are not FDA approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. FDA: concerns about unapproved GLP-1 drugs.

For a compounded prescription, give your clinician the exact pharmacy label and formulation. This is general education for adults, not individualized medical advice or a complete list of drug warnings. Read your own Medication Guide and consult your prescribing clinician.

Related educational guides: Zepbound side effects, tirzepatide and constipation, and Zepbound dizziness. Each addresses a different symptom; none identifies the cause of an individual episode.

Telehealth prescribing rules differ by state. Read the state-by-state guide.